Mid-Size Pharmaceutical Market Size, Top Players, and Forecast by 2031
Mid-Size Pharmaceutical Market: Strategic Insights
Mid-Size Pharmaceutical Market
-
CAGR (2023 - 2031)8.9% -
Market Size 2023
US$ 732.02 Billion -
Market Size 2031
US$ 1,224.039 Billion
Market Dynamics
GROWTH DRIVERS
- Rising Investment towards Improvement of Pharmaceutical Manufacturing Capabilities to boost the mid-size pharmaceutical market
FUTURE TRENDS
- Adoption of Tech Transfer and Outsourcing Trends providing a significant growth opportunity for the mid-size pharmaceutical market
OPPORTUNITIES
- Active participation of market players in product innovation and developments fuel the growth of the mid-size pharmaceutical market
Key Players
- DAIICHI SANKYO COMPANY LIMITED
- Eisai Co Ltd
- Regeneron Pharmaceuticals Inc
- Bausch Health Companies Inc
- Sun Pharmaceutical Industries Ltd
- Alexion Pharmaceuticals Inc
- Mallinckrodt
- Endo Pharmaceuticals Inc
- Les Laboratories Servier
- UCB S A
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type - Prescription
- Over the Counter
Drug Development Type - in-house and outsource
Formulation - tablets & capsules
- injectables
- sprays
- other formulations
Therapy Class - Cardiovascular Diseases
- Pain Management
- Diabetes
- Cancer
- Other Conditions
Get Free Sample For